Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
---|
10/02/2014 | WO2014159937A1 Cyclic peptoid oligomers, pharmaceutical compositions and methods of using the same |
10/02/2014 | WO2014159878A2 Intranasal administration of guanidinylated aminoglycosides |
10/02/2014 | WO2014159745A1 Combinations of bruton's tyrosine kinase inhibitors and cyp3a4 inhibitors |
10/02/2014 | WO2014159559A1 Fused furans for the treatment of hepatitis c |
10/02/2014 | WO2014159076A1 Inhibitors of human immunodeficiency virus replication |
10/02/2014 | WO2014158963A1 Antibodies targeted to fungal cell wall polysaccharides |
10/02/2014 | WO2014158761A1 Aromatic carboxylic acids in combination with aromatic hydroxyamides for inactivating non-enveloped viruses |
10/02/2014 | WO2014158123A1 Gene optimized hantaan virus m segment dna vaccine for hemorrhagic fever with renal syndrome |
10/02/2014 | WO2014158045A1 Dimeric quaternary pyridinium salts possessing biocidal activity |
10/02/2014 | WO2014157622A1 Antiviral agent against non-enveloped viruses and use thereof |
10/02/2014 | WO2014157595A1 Novel polypeptides and utilization thereof |
10/02/2014 | WO2014157380A1 Therapeutic agent for wounds or fibrosis |
10/02/2014 | WO2014157174A1 Composition for body, and anti-fungal agent against malassezia |
10/02/2014 | WO2014157107A1 Polypeptide having sialylated sugar chains attached thereto |
10/02/2014 | WO2014155301A1 Substituted bicyclic compounds as inhibitors of ezh2 |
10/02/2014 | WO2014155097A1 Inhibitor for treatment of hcv infection |
10/02/2014 | WO2014154921A1 Method for the synthesis of homologous compounds of azanucleosides |
10/02/2014 | WO2014154899A1 Use of a macrocyclic lactone for treating a complication from a papillomavirus infection |
10/02/2014 | WO2014154891A1 Cgrp receptor agonist for hiv treatment or prevention |
10/02/2014 | WO2014154134A1 Polypeptide having inhibitory effect against infection by novel coronavirus hcov-emc 2012 and application of the polypeptide |
10/02/2014 | WO2014153674A1 Influenza virus-like particle production in plants |
10/02/2014 | WO2014153624A1 Antibacterial compounds |
10/02/2014 | US20140296498 Tiacumicin Production |
10/02/2014 | US20140294935 Vaccine composition |
10/02/2014 | US20140294892 Construction of west nile virus and dengue virus chimeras for use in a live virus vaccine to prevent disease caused by west nile virus |
10/02/2014 | US20140294884 Meningococcus adhesins nada, app and orf 40 |
10/02/2014 | US20140294763 Peptidomimetic protease inhibitors |
10/01/2014 | EP2784075A1 Hepatitis C virus inhibitors |
10/01/2014 | EP2782922A1 Antibacterial tylosin derivatives and methods for their preparation |
10/01/2014 | EP2782597A1 Nucleic acid vaccines against herpes simplex virus type 2: compositions and methods for eliciting an immune response |
10/01/2014 | EP2782589A2 Anti-microbial peptides and methods of use thereof |
09/30/2014 | US8846893 Non-ionically bound constructs, and compositions and kits comprising domains |
09/30/2014 | US8846696 Purine derivatives |
09/30/2014 | US8846650 Method of treating middle ear infections |
09/30/2014 | US8846609 Leukotoxin E/D as a new anti-inflammatory agent and microbicide |
09/30/2014 | US8846607 Particles for treatment of pulmonary infection |
09/30/2014 | US8846026 Composition comprising immunogenic microparticles |
09/25/2014 | WO2014152635A1 Combination of direct acting antiviral agents and ribavirin for treating hcv patients |
09/25/2014 | WO2014152514A1 Combination of two antivirals for treating hepatitis c |
09/25/2014 | WO2014152444A1 Histone deacetylase inhibitors |
09/25/2014 | WO2014152332A1 Methods of treating infections in overweight and obese patients using antibiotics |
09/25/2014 | WO2014152275A1 Deuterium modified derivatives of the ns5b polymerase inhibitor tmc647055 |
09/25/2014 | WO2014152231A1 Methods and compositions for bacteriophage therapy |
09/25/2014 | WO2014151837A1 A bacillus subtilis strain for use in maintaining or improving the paw health of poultry |
09/25/2014 | WO2014151771A1 Compositions and methods for treating an immunodeficiency virus infection |
09/25/2014 | WO2014151719A1 Sublingual formulations including geranylgeranylacetone and geranylgeranylacetone derivatives |
09/25/2014 | WO2014151567A1 Oral care compositions containing deoxy sugar antimetabolites |
09/25/2014 | WO2014151526A1 Biological therapeutics for infection-relating disorders or conditions |
09/25/2014 | WO2014151258A1 Substituted pyridine derivatives useful as c-fms kinase inhibitors |
09/25/2014 | WO2014151085A1 Beraprost isomer as agent for the treatment of viral infection |
09/25/2014 | WO2014150094A1 Butyrogenic bacteria as probiotics to treat clostridium difficile |
09/25/2014 | WO2014149526A1 Phenylephrine resinate particles |
09/25/2014 | WO2014149525A1 Phenylephrine resinate particles and use thereof in pharmaceutical formulations |
09/25/2014 | WO2014148949A1 Alkyl 2-{[(2r,3s,5r)-5-(4-amino-2-oxo-2н-pyrimidin-1-yl)-3-hydroxy- tetrahydro-furan-2-yl-methoxy]-phenoxy-phosphoryl-amino}-propionates, nucleoside inhibitors of hcv ns5b rna-polymerase, and methods for producing and use thereof |
09/25/2014 | WO2014148638A1 Aptamer to il-17 and use thereof |
09/25/2014 | WO2014148574A1 Inhibition of production of il-2 |
09/25/2014 | WO2014148438A1 Therapeutic agent for hepatitis c which comprises 4-(1,1,1,3,3,3-hexafluoro-2-hydroxypropan-2-yl)benzene derivative |
09/25/2014 | WO2014148422A1 Licorice hydrolysis extraction composition |
09/25/2014 | WO2014147581A1 Plant extracts of ptaeroxylon obliquum and compounds having antimicrobial and antihelminthic activity |
09/25/2014 | WO2014147405A1 Combination comprising zidovudine and polymyxin |
09/25/2014 | WO2014147287A1 Nanocrystalline cellulose (ncc) as an antiviral compound |
09/25/2014 | WO2014147178A1 Hdac6 inhibitors and uses thereof |
09/25/2014 | WO2014147095A1 Lipohillic oligonucleotide analogs |
09/25/2014 | WO2014146603A1 Pasteurella multocida toxin recombinant protein and use thereof |
09/25/2014 | WO2014146218A1 Usage of mycophenolate mofetil or salt thereof in preparing drug for resisting against influenza virus |
09/25/2014 | US20140288266 Synthesis of Cyclosporin Analogs |
09/25/2014 | US20140287028 Use of Chemotherapeutic Agents |
09/24/2014 | EP2781525A2 Novel derivatives of hemin with antibacterial and antiviral activity |
09/24/2014 | EP2781523A1 Lipophilic oligonucleotide analogs |
09/24/2014 | EP2781519A1 Novel antiviral pyrrolopyridine derivative and a production method for same |
09/24/2014 | EP2781517A1 Nitrogenated heterocyclic compound |
09/24/2014 | EP2781510A1 HIV inhibiting 5,6-substituted pyrimidines |
09/24/2014 | EP2781221A1 Medicine for treatment and/or improvement of sepsis |
09/24/2014 | EP2780371A1 Anti-adrenomedullin (adm) antibody or anti-adm antibody fragment or anti-adm non-ig scaffold for regulating the fluid balance in a patient having a chronic or acute disease |
09/24/2014 | EP2780370A1 Anti-adrenomedullin (adm) antibody or anti-adm antibody fragment or anti-adm non-ig scaffold for use in therapy of an acute disease or acute condition of a patient for stabilizing the circulation |
09/24/2014 | EP2780369A1 Anti-adrenomedullin (adm) antibody or anti-adm antibody fragment or anti-adm non-ig scaffold for prevention or reduction of organ dysfunction or organ failure in a patient having a chronic or acute disease or acute condition |
09/24/2014 | EP2780366A2 Rsv g protein specific antibodies |
09/24/2014 | EP2780365A1 Lactoferrin derived peptides for use as broad- spectrum inhibitors of influenza virus infection |
09/24/2014 | EP2780361A1 Conjugates of gm-csf and il-7, compositions and methods related thereto |
09/24/2014 | EP2780352A1 Mannosylated compounds useful for the prevention and the treatment of infectious diseases |
09/24/2014 | EP2780351A1 Clostridium difficile lipoteichoic acid and uses thereof |
09/24/2014 | EP2780350A2 Synthetic derivatives of mpl and uses thereof |
09/24/2014 | EP2780038A1 Vaccine comprising a tlr-5 agonist as adjuvant for use in cutaneous immunisation |
09/24/2014 | EP2780007A1 Apricitabine and pi combination therapy |
09/23/2014 | US8841433 Metapneumovirus strains and their use in vaccine formulations and as vectors for expression of antigenic sequences |
09/23/2014 | US8841420 Synthetic peptide constructs for the diagnosis and treatment of periodontis associated with Porphyromonas gingivalis |
09/23/2014 | US8841310 Combinations of a pyrimidine containing NNRTI with RT inhibitors |
09/23/2014 | US8841307 Method of using diketopiperazines and composition containing them |
09/23/2014 | US8841278 Antiviral compounds |
09/23/2014 | US8840934 Uses of ammonium chloride |
09/23/2014 | US8840932 Antiseptic compositions and methods |
09/23/2014 | CA2688142C A process for stereoselective synthesis of lamivudine |
09/23/2014 | CA2672261C Methods for treating cystic fibrosis or pneumonia with bacterial infection via pulmonary administration of fosfomycin |
09/23/2014 | CA2608977C Antifungal agents |
09/23/2014 | CA2608153C Thiazole derivatives for use as p13k modulators |
09/23/2014 | CA2602121C Pharmaceutical composition and method using an antifungal arylamidine in combination |
09/23/2014 | CA2548990C Toll-like receptor 4 (tlr4)-neutralizing antibodies |
09/23/2014 | CA2546926C Compositions for the treatment of afflictions of the oral cavity and upper respiratory tract |
09/18/2014 | WO2014145600A1 Ach-0142684 sodium salt polymorphs, composition including the same, and method of manufacture thereof |
09/18/2014 | WO2014145507A1 A process for making a 4-amino-4-oxobutanoyl peptide cyclic analogue, an inhibitor of viral replication, and intermediates thereof |